6550--hemochron signature elite reagents and supplies
Open Solicitation Posted
- Solicitation number
- 36C26227Q0111
- Agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Department of Veterans Affairs Southern Arizona Healthcare System Tucson, Arizona 85723, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Network Contracting Office 22 is procuring Hemochron Signature Elite reagents and supplies on behalf of VHA Veterans Integrated Service Network 22 under Solicitation 36C26227Q0111, with responses due November 27, 2026 at 12:00 PM Pacific Time. No set-aside is used.
Place of performance is the VA Southern Arizona Healthcare System, 3601 S 6th Ave, Tucson, Arizona 85723. The contracting office is at 4811 Airport Plaza Drive, Suite 600, Long Beach, California 90815, and the contract specialist is Rebecca Gaba (Rebecca.Gaba@va.gov). The notice is classified under NAICS 325413 and PSC 6550.
Per the Attachment B statement of work summary, the contractor must deliver reagents and supplies to designated VA facilities, maintain inventory levels, and provide technical support as needed, with specifications aligned to FDA-approved Hemochron Signature Elite formulations. Per the Attachment A summary, the blank pricing schedule lists six line items of activated clotting time (ACT) products across a base period and four option periods, with identical quantities in each period: ACT Low Range test cuvettes (70 units), Direct Check Abnormal ACT LR control vials (14 units), Direct Check Normal ACT LR control vials (14 units), Hemochron JACT test cuvettes in 45-unit boxes (40 units), Direct Check Abnormal ACT control vials (14 units), and Direct Check Normal ACT control vials (14 units). All quantities are priced per each (EA).
The source states no evaluation criteria, award value, budget, or incumbent.
Notice text
See attached. Thank you.
Files
| File | Type | Posted |
|---|---|---|
| ATTACHMENT B SOW Hemochron Reagents.docx | DOCX document | |
| Attachment A HEMOCHRON.xlsx | XLSX spreadsheet | |
| S02 36C26227Q0111 RFQ HEMOCHRON.docx | DOCX document | |
| 36C26227Q0111 RFQ.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6550--Blood Type IVD Reagents | Veterans Integrated Service Network 22 | No set-aside | |
| 6550--Abbott Architect i1000 Reagents | Veterans Integrated Service Network 22 | Total Small Business | |
| 6632--Cath Lab GEM 5000 | Veterans Integrated Service Network 6 | No set-aside | |
| VA Boise, Idaho Medical Center Lab - New Blood Reagents Requirement | Veterans Integrated Service Network 20 | No set-aside | |
| 6550--VISN 4 Coagulation Testing | Veterans Integrated Service Network 4 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity